COST-EFFECTIVENESS OF DAPTOMYCIN IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND BACTEREMIA CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN TURKEY

被引：0
|
作者：
Pala, M. [1 ]
Gol, D. [1 ]
机构：
[1] Novartis Turkey, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73301-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A550 / A550
页数：1
相关论文
共 50 条
  • [21] VANCOMYCIN CREEP PHENOMENON IN METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTIVE ENDOCARDITIS
    Munoz, P.
    Rodriguez-Creixems, M.
    Cercenado, E.
    Marin, M.
    Buzon, L.
    Roda, J.
    Gonzalez-Ramallo, V.
    Martinez-Selles, M.
    Pinilla, B.
    Segado, A.
    Fernandez-Cruz, A.
    Valerio, M.
    Giannella, M.
    Bermejo, J.
    Pinto, A.
    Bouza, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 : S34 - S34
  • [22] MODERATOR BAND ENDOCARDITIS CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
    Teshome, M. K.
    Asfaw, A. A.
    Hesterberg, K.
    Woods, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 398 - 399
  • [23] Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus
    Sakoulas, G
    Eliopoulos, GM
    Alder, J
    Thauvin-Eliopoulos, C
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) : 1714 - 1718
  • [24] Ineffectiveness of Daptomycin in the Treatment of Septic Pulmonary Emboli and Persistent Bacteremia Caused by Methicillin-resistant Staphylococcus aureus
    Hagiya, Hideharu
    Hagioka, Shingo
    Otsuka, Fumio
    INTERNAL MEDICINE, 2013, 52 (22) : 2577 - 2582
  • [25] Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis
    Hill, E. E.
    Peetermans, W. E.
    Vanderschueren, S.
    Claus, P.
    Herregods, M. -C.
    Herijgers, P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (06) : 445 - 450
  • [26] Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis
    E. E. Hill
    W. E. Peetermans
    S. Vanderschueren
    P. Claus
    M.-C. Herregods
    P. Herijgers
    European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 445 - 450
  • [27] COST-EFFECTIVENESS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NASAL SWABS IN PNEUMONIA
    Kedzior, Sonya
    Minor, Noah
    Molina, Kyle
    Mueller, Scott
    Miller, Matthew
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 625 - 625
  • [28] Methicillin resistant Staphylococcus aureus bacteremia
    De Araujo Otero, Stephanie
    Lagrutta, Mariana
    Negro Marquinez, Liliana
    Paro-Di, Roberto
    Perez, Jorgelina
    Falco, Gabriela
    Greca, Alcides
    REVISTA MEDICA DE ROSARIO, 2019, 85 (03): : 113 - 125
  • [29] Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
    Falcone, Marco
    Russo, Alessandro
    Venditti, Mario
    Novelli, Andrea
    Pai, Manjunath P.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (11) : 1568 - 1576
  • [30] Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Kaye, Keith S.
    Patel, Twisha
    Drusano, George
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
12345